Populations and Methods Used to Define Prostate Cancer Polygenic Risk Score Categories Impact the Interpretation of Risk

被引：0
|
作者：
Guo, Boya [1 ]
Sahimi, Ali [2 ]
Sheng, Xin [3 ]
Chen, Fei [3 ]
Haiman, Christopher A. [3 ]
Conti, David V. [3 ]
Darst, Burcu F. [1 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] NYU, Grossman Sch Med, New York, NY USA
[3] Univ Southern Calif, Ctr Genet Epidemiol, Dept Prevent Med, Keck Sch Med,Norris Comprehens Canc Ctr, Los Angeles, CA USA
来源：
GENETIC EPIDEMIOLOGY | 2024年 / 48卷 / 07期
关键词：
polygenic risk scores; prostate cancer; diverse populations; genetic epidemiology; multi-ancestry;
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
33
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [41] Genomic prostate score and treatment selection in favourable intermediate-risk prostate cancer
    Margolis, Eric
    Lowentritt, Benjamin H.
    Pieczonka, Christopher M.
    Bennett, John P.
    Pavlova, Marina
    Zambon, Joao Paulo
    Groskopf, Jack
    Uchio, Edward
    BJUI COMPASS, 2025, 6 (03):
  • [42] Metabolic syndrome in prostate cancer: impact on risk and outcomes
    Karzai, Fatima H.
    Madan, Ravi A.
    Dahut, William L.
    FUTURE ONCOLOGY, 2016, 12 (16) : 1947 - 1955
  • [43] Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
    Jong Jin Oh
    Hyungwoo Ahn
    Sung Il Hwang
    Hak Jong Lee
    Gheeyoung Choe
    Sangchul Lee
    Hakmin Lee
    Seok-Soo Byun
    Sung Kyu Hong
    BMC Urology, 21
  • [44] Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
    Oh, Jong Jin
    Ahn, Hyungwoo
    Hwang, Sung Il
    Lee, Hak Jong
    Choe, Gheeyoung
    Lee, Sangchul
    Lee, Hakmin
    Byun, Seok-Soo
    Hong, Sung Kyu
    BMC UROLOGY, 2021, 21 (01)
  • [45] The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region
    Okayama, A.
    Ueshima, H.
    Maegawa, H.
    Aoki, N.
    Nakamura, M.
    Kubo, N.
    Yamada, T.
    Wu, Z. S.
    Yao, C. H.
    Wu, Z. S.
    Andrews, G.
    Welborn, T. A.
    Tang, Z.
    Liu, L. S.
    Xie, J. X.
    Norton, R.
    Ameratunga, S.
    MacMahon, S.
    Whitlock, G.
    Knuiman, M. W.
    Christensen, H.
    Zhou, J.
    Yu, X. H.
    Wu, X. G.
    Tarnakoshi, A.
    Pan, W. H.
    Sritara, P.
    Wu, Z. L.
    Chen, L. Q.
    Shan, G. L.
    Gu, Df
    Duan, X. F.
    Norton, R.
    Whitlock, G.
    Jackson, R.
    Li, Y. H.
    Fujishima, M.
    Kiyohara, Y.
    Iwamoto, H.
    Woo, J.
    Ho, S. C.
    Hong, Z.
    Huang, M. S.
    Zhou, B.
    Fuh, J. L.
    Ueshima, H.
    Kita, Y.
    Choudhury, S. R.
    Suh, I.
    Jee, S. H.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2007, 8 (02) : 199 - 205
  • [46] Localized prostate cancer: can we better define who is at risk of unfavourable outcome?
    Joniau, Steven
    Van Poppel, Hein
    BJU INTERNATIONAL, 2008, 101 : 5 - 10
  • [47] Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score
    Helfand, Brian T.
    Chen, Haitao
    Fantus, Richard J.
    Conran, Carly A.
    Brendler, Charles B.
    Zheng, Siquan Lilly
    Walsh, Patrick C.
    Isaacs, William B.
    Xu, Jianfeng
    PROSTATE, 2018, 78 (14) : 1063 - 1068
  • [48] Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
    Kim, Michelle S.
    Naidoo, Daphne
    Hazra, Ujani
    Quiver, Melanie H.
    Chen, Wenlong C.
    Simonti, Corinne N.
    Kachambwa, Paidamoyo
    Harlemon, Maxine
    Agalliu, Ilir
    Baichoo, Shakuntala
    Fernandez, Pedro
    Hsing, Ann W.
    Jalloh, Mohamed
    Gueye, Serigne M.
    Niang, Lamine
    Diop, Halimatou
    Ndoye, Medina
    Snyper, Nana Yaa
    Adusei, Ben
    Mensah, James E.
    Abrahams, Afua O. D.
    Biritwum, Richard
    Adjei, Andrew A.
    Adebiyi, Akindele O.
    Shittu, Olayiwola
    Ogunbiyi, Olufemi
    Adebayo, Sikiru
    Aisuodionoe-Shadrach, Oseremen, I
    Nwegbu, Maxwell M.
    Ajibola, Hafees O.
    Oluwole, Olabode P.
    Jamda, Mustapha A.
    Singh, Elvira
    Pentz, Audrey
    Joffe, Maureen
    Darst, Burcu F.
    Conti, David, V
    Haiman, Christopher A.
    Spies, Petrus, V
    van der Merwe, Andre
    Rohan, Thomas E.
    Jacobson, Judith
    Neugut, Alfred, I
    McBride, Jo
    Andrews, Caroline
    Petersen, Lindsay N.
    Rebbeck, Timothy R.
    Lachance, Joseph
    GENOME BIOLOGY, 2022, 23 (01)
  • [49] Erythrocyte fatty acids and prostate cancer risk: A comparison of methods
    Shannon, J.
    O'Malley, J.
    Mori, M.
    Garzotto, M.
    Palma, A. J.
    King, I. B.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2010, 83 (03): : 161 - 169
  • [50] Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis
    Zhang, Wensheng
    Zhang, Kun
    CANCER INFORMATICS, 2024, 23
12345